HRT Financial’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-11,010
Closed -$3K 2632
2023
Q1
$3K Sell
11,010
-23,351
-68% -$8.85K ﹤0.01% 2323
2022
Q4
$8K Sell
34,361
-37,545
-52% -$11.5K ﹤0.01% 2236
2022
Q3
$30K Sell
71,906
-31,793
-31% -$18.8K ﹤0.01% 2467
2022
Q2
$53K Sell
103,699
-28,558
-22% -$15.9K ﹤0.01% 2505
2022
Q1
$80K Buy
+132,257
New +$72.1K ﹤0.01% 2698

Other funds holding DRTSW

HRT Financial's DRTSW Position: Q2 2023 in Review

HRT Financial sold out of Alpha Tau Medical Warrant (DRTSW) in Q2 2023, closing a stake of 11,010 shares — an estimated $3K sold.

HRT Financial first reported a position in DRTSW in Q1 2022 and held it in 5 quarters. The position peaked at $80K in Q1 2022. 28 funds tracked by Wall St. Rank hold DRTSW as of Q2 2023.

  • HRT Financial reported no remaining Alpha Tau Medical Warrant position as of Q2 2023 after selling out during the quarter.
  • HRT Financial sold 11,010 Alpha Tau Medical Warrant shares in Q2 2023, an estimated $3K.
  • HRT Financial first reported a position in Alpha Tau Medical Warrant in Q1 2022 and held it in 5 quarters.
  • HRT Financial's Alpha Tau Medical Warrant position peaked at $80K in Q1 2022.
  • 28 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q2 2023.

Based on HRT Financial's 13F filing for Q2 2023, filed 11 Aug 2023.